At this ACR Convergence 2024 session, discussion centered on novel techniques that offer hope for developing personalized therapies for pediatric SLE.
Initiative Trains Clinicians About RA for the Navajo Community
The Rheumatology Access Expansion Initiative helps meet the needs of patients with rheumatoid arthritis in an underserved community in the U.S.
Multiple ACR-Supported Policies Advance at Interim AMA House of Delegates Meeting
At a busy and highly successful interim meeting of the AMA House of Delegates, an ACR-cosponsored resolution that calls for exceptions to therapy caps was passed and will become AMA policy. Other areas addressed include payment parity for telemedicine and MIPS reform.
RheumCode: Creating a Common Rheumatology Language in EHRs
This ACR initiative aims to create a common language to define key data elements for rheumatology and make it easier to compare patient data across EHR systems.
Lung Cancer in RA & RA-ILD
Brooks et al. evaluated the risk of lung cancer in patients with rheumatoid arthritis (RA) and RA-associated interstitial lung disease (ILD) compared with the risk in matched controls without RA or RA-ILD. Understanding whether RA predisposes someone to lung cancer and whether patients with RA-ILD represent a uniquely high-risk group could inform cancer-screening strategies.
Lupus Nephritis Guideline Encourages Triple Therapy
Screening recommendations, triple therapy and more—here are insights into the upcoming ACR guideline for the care and treatment of patients with lupus nephritis.
As ARP President, Adam Goode, PT, DPT, PhD, Will Draw on Power of Interdisciplinary Members
The diversity of the ARP’s membership is what originally drew Adam Goode, PT, DPT, PhD, to the organization, enticed him to begin volunteering more than a decade ago and now galvanizes him as he becomes the new ARP president.
New ACR President Carol Langford, MD, MHS, Has Optimistic Outlook for Future of Rheumatology
“At my very first annual meeting of the ACR, I saw how the ACR brought the whole rheumatology community together, and I knew right away that it was an organization that I wanted to be a part of,” Dr. Langford says. In late November, she became the 88th president of the ACR and looks forward to continuing its focus on education, research and building community.
Top Research in Gout from ACR Convergence 2024 at a Glance
Dr. Lisa Stamp helps filter the noise to get to the key insights from the research abstracts on gout presented at ACR Convergence 2024.
The Great Pediatric Debate 2024: Cessation or Continuation of Biologics in sJIA Lung Disease?
Washington D.C.—At a Sunday, Nov. 17, Pediatrics Great Debate session of ACR Convergence, speakers argued whether patients with systemic juvenile idiopathic arthritis (sJIA) should continue their interleukin (IL) 1/IL-6 biologics if lung disease is suspected. Randy Q. Cron, MD, PhD, the director of the Division of Pediatric Rheumatology at the University of Alabama at Birmingham,…
- « Previous Page
- 1
- …
- 12
- 13
- 14
- 15
- 16
- …
- 812
- Next Page »